PHARMALAB ApS: Financial statements 2019
CVR: 33058101
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
PHARMALAB ApS (CVR 33058101) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -28,250 and a net result of DKK -22,849 compared with DKK 286,415 the year before. Equity in the 2019 report amounted to DKK -27,444.
- Gross Profit
- DKK -28,250
- Profit/Loss
- DKK -22,849
- Equity
- DKK -27,444
- Total Assets
- DKK 31,076
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -28 t. | -23 t. | -27 t. | - |
| 2018 | - | -138 t. | 286 t. | -5 t. | - |
| 2017 | - | 8 t. | -22 t. | -291 t. | 0 |
| 2016 | - | -198 t. | -216 t. | -269 t. | - |
| 2015 | - | -135 t. | -148 t. | -54 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
PHARMALAB ApS has published its annual report for 2018. Gross profit came to DKK -138,224, and the net result was DKK 286,415.
About PHARMALAB ApS
PHARMALAB ApS was a Danish company of the type Anpartsselskab based in Hårlev, founded in 2010. The company has been dissolved on 18 March 2025. The company was registered under the industry Fremstilling af andre maskiner til generelle formål i.a.n.. According to the 2023 annual report, the company had an average of 1 employee. In 2023, the company reported a gross profit of DKK -42,256 and a net result of DKK -31,505 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK -107,589.